NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Amphastar Wins FDA Approval for Affordable Osteoporosis Treatment

Amphastar Pharmaceuticals receives FDA approval for generic teriparatide injection, offering an affordable alternative to Eli Lilly's FORTEO for osteoporosis patients.

Amphastar Wins FDA Approval for Affordable Osteoporosis Treatment
Photo by Danielle Barnes on Unsplash
Already have an account? Sign in.
12/15/2025 · 11:34 AM
AMPH
/ Read more

Feed↓

Infleqtion Posts Record Q2 Revenue but Shares Drop on Wider Losses and Dilution Concerns
08/12/2026 · 6:12 PM

Infleqtion Posts Record Q2 Revenue but Shares Drop on Wider Losses and Dilution Concerns

Infleqtion posted record $12.6M Q2 revenue (up 116%) and raised outlook to $43M.

/ Subscriber only
Virgin Galactic Shares Fall After Delaying First Commercial Flight to February 2027
08/12/2026 · 5:49 PM

Virgin Galactic Shares Fall After Delaying First Commercial Flight to February 2027

SPCE stock drops as Virgin Galactic delays first commercial Delta-class flight to February 2027, despite Q2 earnings beat and strong ticket demand.

/ Subscriber only
PTC Acquires Near-Approval ST-920 Fabry Gene Therapy in Bankruptcy Auction
08/12/2026 · 5:09 PM

PTC Acquires Near-Approval ST-920 Fabry Gene Therapy in Bankruptcy Auction

PTC Therapeutics acquires BLA-stage ST-920, a one-time AAV gene therapy for Fabry disease, with potential U.S. launch in 2027 and strong clinical data.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe